Tag Archives: Darren Collins

Medical Cannabis Symposium

Khiron Life Sciences Corp. to host first international medical cannabis symposium

Khiron Life Sciences Corp. to host first international medical cannabis symposium

TORONTO, Ontario, Jan. 24, 2018 /Weed Wire/ – Khiron Life Sciences Corp., a Canadian integrated medical cannabis company with its core operations in Colombia, will welcome Colombia’s medical community as co-host of the inaugural International Medical Cannabis Symposium taking place Feb. 15 in Bogotá, Colombia.

Medical Cannabis Symposium

Khiron Receives Cultivation Quota From Colombian Government and Commences Cultivation

TORONTO, Ontario, Dec. 28, 2017 /Weed Wire/ — Khiron Life Sciences Corp. (“Khiron” or the “Company”) reports that the Company’s wholly owned subsidiary, Khiron Colombia SAS, has commenced cultivation of a variety of medical grade cannabis strains in accordance with the receipt of its medical cannabis quota allocation provided by the Government of Colombia.

Medical Cannabis Symposium

Khiron First Company to be Fully Licensed for High and Low THC Medical Cannabis in Colombia

TORONTO, Ontario, Oct. 23, 2017 /Weed Wire/ — Khiron Life Sciences Corp. reports that further to its press release dated September 26, 2017, the Company’s wholly owned subsidiary, Khiron Colombia SAS, has been granted all the licences required for the cultivation, production, domestic distribution and international export of both low and high tetrahydrocannabinol (“THC”) medical cannabis in the country of Colombia.

Medical Cannabis Symposium

Khiron Advisor Featured as Part of Joint Investigation by 60 Minutes and the Washington Post on U.S. Opioid Crisis

TORONTO, Ontario, Oct. 13, 2017 /Weed Wire/ — Khiron Life Sciences Corp. (“Khiron” or the “Company”) reports that Matthew Murphy, Security and Compliance Advisor to Khiron, and former U.S. DEA Chief of Pharmaceutical Investigations, will be featured as part of a 60 Minutes and Washington Post joint investigation on the U.S. opioid crisis.

Medical Cannabis Symposium

Khiron Appoints Former DEA Chief of Pharmaceutical Investigations to Advisory Board

ORONTO, Ontario, Sept. 29, 2017 /Weed Wire/ — Khiron Life Sciences Corp. (“Khiron” or the “Company”) reports the appointment of Mr. Matthew Murphy, the former U.S. Drug Enforcement Administration (“DEA”) Chief of Pharmaceutical Investigations, to the Advisory Board of the Company.


Top